A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study.
Fouladi M, Perentesis JP, Phillips CL, Leary S, Reid JM, McGovern RM, Ingle AM, Ahern CH, Ames MM, Houghton P, Doyle LA, Weigel B, Blaney SM.
Fouladi M, et al. Among authors: blaney sm.
Pediatr Blood Cancer. 2014 Jul;61(7):1246-51. doi: 10.1002/pbc.25023. Epub 2014 Mar 24.
Pediatr Blood Cancer. 2014.
PMID: 24664955
Free PMC article.
Clinical Trial.